Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 20.54 billion as of June 29, 2026. Its market cap has increased by 27.51% in one year.

Market Cap

20.54B

Enterprise Value

21.33B

Revenue

2.40B

Ranking

n/a

PE Ratio

72.36

Stock Price

12.84

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 20.54B, an increase of 50.61%. That is a compound annual growth rate of 2.65%.

Market Cap History

Date	Market Cap	% Change
Jun 29, 2026	20.54B	17.69%
Dec 31, 2025	17.45B	-9.69%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Zhejiang Huahai Pharmaceutical	20.88B
Jilin Aodong Pharmaceutical Group	20.56B
Tasly Pharmaceutical Group	19.78B
Guangdong Zhongsheng Pharmaceutical	19.20B
Shanghai Haoyuan Chemexpress	19.12B
Jiangsu Nhwa Pharmaceutical Co., LTD	18.52B
Chengdu Kanghong Pharmaceutical Group	17.98B
Apeloa Pharmaceutical Co.,Ltd	17.97B

Market Cap Rankings